Literature DB >> 3791688

Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.

P J Watt, M Zardis, P R Lambden.   

Abstract

Respiratory syncytial virus (RSV) fusion protein was purified by immunoaffinity chromatography using a mouse monoclonal antibody coupled to Affi-gel 10. The fusion protein was homogeneous by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and free of other detectable viral or cellular protein. The purified fusion protein was used in a quantitative enzyme-linked immunosorbent assay (ELISA) to measure the age-related antibody response to this protein in infected infants. The four IgG subclasses, IgA and IgM levels were determined for infants under 6 months of age, infants aged 6 months to 1 year and infants aged 1 year and over. Most infants over 6 months of age showed marked increases in both IgG1 and IgG3 antibodies with poor or negligible response with IgG2 and IgG4. By contrast infants under 6 months failed to respond by the production of IgG antibodies, although increases in IgA and IgM levels were observed. These data may explain the failure of primary RSV infections to induce protective immunity and have implications for the strategic use of attenuated RSV vaccines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791688      PMCID: PMC1542426     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

2.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

3.  IgG subclass levels in infancy and childhood.

Authors:  V A Oxelius
Journal:  Acta Paediatr Scand       Date:  1979-01

4.  Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers.

Authors:  D Y Bell; J A Haseman; A Spock; G McLennan; G E Hook
Journal:  Am Rev Respir Dis       Date:  1981-07

5.  Parenteral immunization with live respiratory syncytial virus is blocked in seropositive cotton rats.

Authors:  G A Prince; R L Horswood; E Camargo; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects. Quantitation and comparison with immunoglobulins A and E.

Authors:  W W Merrill; G P Naegel; J J Olchowski; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1985-04

7.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

8.  Comparison of enzyme-linked immunosorbent assay and neutralization techniques for measurement of antibody to respiratory syncytial virus: implications for parenteral immunization with live virus vaccine.

Authors:  R B Belshe; L P Van Voris; M A Mufson; E B Buynak; A A McLean; M A Hilleman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Maternal antibody and respiratory syncytial virus infection in infancy.

Authors:  M M Ogilvie; A S Vathenen; M Radford; J Codd; S Key
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

10.  Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.

Authors:  W P Glezen; A Paredes; J E Allison; L H Taber; A L Frank
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

View more
  14 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  IgG subclass-containing cells in the human large bowel of normal controls, non-IBD colitis, and ulcerative colitis.

Authors:  M Iizuka
Journal:  Gastroenterol Jpn       Date:  1990-02

3.  Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.

Authors:  D K Wagner; P Muelenaer; F W Henderson; M H Snyder; C B Reimer; E E Walsh; L J Anderson; D L Nelson; B R Murphy
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

4.  Respiratory syncytial virus and the infant immune response.

Authors:  G L Toms; R Scott
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

Review 5.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 6.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

7.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein.

Authors:  B S Robinson; J S Everson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus.

Authors:  N P Leschinskaya; E E Pokrovskaya; E A Kantorovitch; S K Grigorjeva
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.